JP2003169823A - Patch - Google Patents
PatchInfo
- Publication number
- JP2003169823A JP2003169823A JP2002252700A JP2002252700A JP2003169823A JP 2003169823 A JP2003169823 A JP 2003169823A JP 2002252700 A JP2002252700 A JP 2002252700A JP 2002252700 A JP2002252700 A JP 2002252700A JP 2003169823 A JP2003169823 A JP 2003169823A
- Authority
- JP
- Japan
- Prior art keywords
- patch
- knitted fabric
- modulus
- elongation recovery
- support
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004744 fabric Substances 0.000 claims abstract description 45
- 229920005989 resin Polymers 0.000 claims abstract description 41
- 239000011347 resin Substances 0.000 claims abstract description 41
- 239000000017 hydrogel Substances 0.000 claims description 18
- 230000008602 contraction Effects 0.000 abstract description 15
- 238000011084 recovery Methods 0.000 description 45
- 239000010410 layer Substances 0.000 description 42
- -1 polyethylene Polymers 0.000 description 32
- 238000009940 knitting Methods 0.000 description 27
- 239000000499 gel Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 229920002125 Sokalan® Polymers 0.000 description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 16
- 150000003839 salts Chemical class 0.000 description 14
- 238000004873 anchoring Methods 0.000 description 13
- 239000011505 plaster Substances 0.000 description 12
- 239000004584 polyacrylic acid Substances 0.000 description 12
- 229920000728 polyester Polymers 0.000 description 11
- 239000000853 adhesive Substances 0.000 description 10
- 230000001070 adhesive effect Effects 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000010408 film Substances 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- 229920002635 polyurethane Polymers 0.000 description 9
- 239000004814 polyurethane Substances 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000004743 Polypropylene Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000004745 nonwoven fabric Substances 0.000 description 6
- 229920001155 polypropylene Polymers 0.000 description 6
- 229920006264 polyurethane film Polymers 0.000 description 6
- 238000003892 spreading Methods 0.000 description 6
- 240000004731 Acer pseudoplatanus Species 0.000 description 5
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 5
- 235000006485 Platanus occidentalis Nutrition 0.000 description 5
- 150000005215 alkyl ethers Chemical class 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- 235000002566 Capsicum Nutrition 0.000 description 4
- 240000008574 Capsicum frutescens Species 0.000 description 4
- 241000723346 Cinnamomum camphora Species 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 229960000846 camphor Drugs 0.000 description 4
- 229930008380 camphor Natural products 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 239000001390 capsicum minimum Substances 0.000 description 4
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 229920000058 polyacrylate Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical class CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- QQRSPHJOOXUALR-UHFFFAOYSA-N Apiole Chemical compound COC1=CC(CC=C)=C(OC)C2=C1OCO2 QQRSPHJOOXUALR-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 240000003538 Chamaemelum nobile Species 0.000 description 3
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 3
- 240000009023 Myrrhis odorata Species 0.000 description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 241001104043 Syringa Species 0.000 description 3
- 240000002657 Thymus vulgaris Species 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229940043430 calcium compound Drugs 0.000 description 3
- 150000001674 calcium compounds Chemical class 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 150000002681 magnesium compounds Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 229920006255 plastic film Polymers 0.000 description 3
- 239000002985 plastic film Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 2
- 235000018185 Betula X alpestris Nutrition 0.000 description 2
- 235000018212 Betula X uliginosa Nutrition 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000005940 Centaurea cyanus Nutrition 0.000 description 2
- 240000004385 Centaurea cyanus Species 0.000 description 2
- 244000301850 Cupressus sempervirens Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 240000006927 Foeniculum vulgare Species 0.000 description 2
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 244000165082 Lavanda vera Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 244000062780 Petroselinum sativum Species 0.000 description 2
- 235000012550 Pimpinella anisum Nutrition 0.000 description 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- 241001092387 Spiraea Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000005844 Thymol Substances 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
- BNWJOHGLIBDBOB-UHFFFAOYSA-N myristicin Chemical compound COC1=CC(CC=C)=CC2=C1OCO2 BNWJOHGLIBDBOB-UHFFFAOYSA-N 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 235000011197 perejil Nutrition 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000002964 rayon Substances 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- 229960000790 thymol Drugs 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- CXENHBSYCFFKJS-UHFFFAOYSA-N (3E,6E)-3,7,11-Trimethyl-1,3,6,10-dodecatetraene Natural products CC(C)=CCCC(C)=CCC=C(C)C=C CXENHBSYCFFKJS-UHFFFAOYSA-N 0.000 description 1
- VYIRVAXUEZSDNC-TXDLOWMYSA-N (3R,3'S,5'R)-3,3'-dihydroxy-beta-kappa-caroten-6'-one Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC(=O)[C@]1(C)C[C@@H](O)CC1(C)C VYIRVAXUEZSDNC-TXDLOWMYSA-N 0.000 description 1
- LFEINUNSYODISY-UHFFFAOYSA-N (ent-5alpha,6beta)-15,16-Epoxy-3,13(16),14-clerodatrien-18,6-olide Natural products CC1CC(C23C)OC(=O)C3=CCCC2C1(C)CCC=1C=COC=1 LFEINUNSYODISY-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- CCJAYIGMMRQRAO-UHFFFAOYSA-N 2-[4-[(2-hydroxyphenyl)methylideneamino]butyliminomethyl]phenol Chemical compound OC1=CC=CC=C1C=NCCCCN=CC1=CC=CC=C1O CCJAYIGMMRQRAO-UHFFFAOYSA-N 0.000 description 1
- DUUKZBGYNMHUHO-UHFFFAOYSA-N 253MC0P0YV Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)CO DUUKZBGYNMHUHO-UHFFFAOYSA-N 0.000 description 1
- DISYHRKLFBBFAS-UHFFFAOYSA-N 3-(1-methyl-4-propan-2-ylcyclohexyl)oxypropane-1,2-diol Chemical compound CC(C)C1CCC(C)(OCC(O)CO)CC1 DISYHRKLFBBFAS-UHFFFAOYSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- WZUKKIPWIPZMAS-UHFFFAOYSA-K Ammonium alum Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O WZUKKIPWIPZMAS-UHFFFAOYSA-K 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 235000007258 Anthriscus cerefolium Nutrition 0.000 description 1
- 240000002022 Anthriscus cerefolium Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- DVHSOAIRLNJAJP-UHFFFAOYSA-N CCC(C)OOC(=O)c1cccnc1 Chemical compound CCC(C)OOC(=O)c1cccnc1 DVHSOAIRLNJAJP-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- VYIRVAXUEZSDNC-LOFNIBRQSA-N Capsanthyn Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CC(O)CC2(C)C VYIRVAXUEZSDNC-LOFNIBRQSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 235000005747 Carum carvi Nutrition 0.000 description 1
- 240000000467 Carum carvi Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241001233914 Chelidonium majus Species 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 235000017897 Cymbopogon citratus Nutrition 0.000 description 1
- 240000004784 Cymbopogon citratus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 244000039154 Erica Species 0.000 description 1
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 240000001812 Hyssopus officinalis Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 235000008227 Illicium verum Nutrition 0.000 description 1
- 240000007232 Illicium verum Species 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- LMXFTMYMHGYJEI-UHFFFAOYSA-N Menthoglycol Natural products CC1CCC(C(C)(C)O)C(O)C1 LMXFTMYMHGYJEI-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 241000269980 Pleuronectidae Species 0.000 description 1
- 235000011751 Pogostemon cablin Nutrition 0.000 description 1
- 240000002505 Pogostemon cablin Species 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000010498 Trifolium agrarium Nutrition 0.000 description 1
- 244000126309 Trifolium dubium Species 0.000 description 1
- WONIGEXYPVIKFS-UHFFFAOYSA-N Verbenol Chemical compound CC1=CC(O)C2C(C)(C)C1C2 WONIGEXYPVIKFS-UHFFFAOYSA-N 0.000 description 1
- 229920002978 Vinylon Polymers 0.000 description 1
- 244000172533 Viola sororia Species 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- 240000007316 Xerochrysum bracteatum Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- MUXFZBHBYYYLTH-UHFFFAOYSA-N Zaltoprofen Chemical compound O=C1CC2=CC(C(C(O)=O)C)=CC=C2SC2=CC=CC=C21 MUXFZBHBYYYLTH-UHFFFAOYSA-N 0.000 description 1
- AZPFEYANVWPOHJ-CLFAGFIQSA-N [2-hydroxy-3-[2-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]propyl] (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCC\C=C/CCCCCCCC AZPFEYANVWPOHJ-CLFAGFIQSA-N 0.000 description 1
- NPTLAYTZMHJJDP-KTKRTIGZSA-N [3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO NPTLAYTZMHJJDP-KTKRTIGZSA-N 0.000 description 1
- ZGBSOTLWHZQNLH-UHFFFAOYSA-N [Mg].S(O)(O)(=O)=O Chemical compound [Mg].S(O)(O)(=O)=O ZGBSOTLWHZQNLH-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 235000011124 aluminium ammonium sulphate Nutrition 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- LCPUDZUWZDSKMX-UHFFFAOYSA-K azane;hydrogen sulfate;iron(3+);sulfate;dodecahydrate Chemical compound [NH4+].O.O.O.O.O.O.O.O.O.O.O.O.[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O LCPUDZUWZDSKMX-UHFFFAOYSA-K 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940065285 cadmium compound Drugs 0.000 description 1
- 150000001662 cadmium compounds Chemical class 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- WRANYHFEXGNSND-LOFNIBRQSA-N capsanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC(=O)C2(C)CCC(O)C2(C)C WRANYHFEXGNSND-LOFNIBRQSA-N 0.000 description 1
- 235000018889 capsanthin Nutrition 0.000 description 1
- 229930185631 capsicoside Natural products 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 150000001845 chromium compounds Chemical class 0.000 description 1
- PUFQVTATUTYEAL-UHFFFAOYSA-N cinchocaine Chemical compound C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCCN(CC)CC)=C21 PUFQVTATUTYEAL-UHFFFAOYSA-N 0.000 description 1
- 229960001747 cinchocaine Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000010632 citronella oil Substances 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 150000001869 cobalt compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000010227 cup method (microbiological evaluation) Methods 0.000 description 1
- 239000001941 cymbopogon citratus dc and cymbopogon flexuosus oil Substances 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- JAUGGEIKQIHSMF-UHFFFAOYSA-N dialuminum;dimagnesium;dioxido(oxo)silane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JAUGGEIKQIHSMF-UHFFFAOYSA-N 0.000 description 1
- PGZIKUPSQINGKT-UHFFFAOYSA-N dialuminum;dioxido(oxo)silane Chemical compound [Al+3].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O PGZIKUPSQINGKT-UHFFFAOYSA-N 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 229930009668 farnesene Natural products 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000010643 fennel seed oil Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- BAZQYVYVKYOAGO-UHFFFAOYSA-M loxoprofen sodium hydrate Chemical compound O.O.[Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 BAZQYVYVKYOAGO-UHFFFAOYSA-M 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 235000012245 magnesium oxide Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 150000002697 manganese compounds Chemical class 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 description 1
- 150000002816 nickel compounds Chemical class 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000001688 paprika extract Substances 0.000 description 1
- 235000012658 paprika extract Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 229920005614 potassium polyacrylate Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Natural products COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 229950004227 zaltoprofen Drugs 0.000 description 1
- 229940100888 zinc compound Drugs 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、貼付剤に関し、よ
り詳しくは、支持体と含水ゲル層との投錨性に優れ、更
に皮膚の伸縮によく追随し、且つ伸長させた後、その伸
長力を解除させた場合(以下、「伸長回復後」という)
もしわが入らず、また、良好な透明性を得ることもでき
る貼付剤に関する。TECHNICAL FIELD The present invention relates to a patch, and more specifically, it has excellent anchoring properties between a support and a hydrous gel layer, and also follows the expansion and contraction of the skin well, and after stretching, its stretching force. When cancelled (hereinafter referred to as "after extension recovery")
The present invention relates to a patch which can be self-reliant and can also obtain good transparency.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】従来か
ら、不織布等の支持体に含水ゲルを展延した貼付剤が知
られているが、支持体として不織布等を単独で使用する
と、貼付剤全体が不透明になり、貼付剤を皮膚に貼る
と、目立ってしまうという問題があった。2. Description of the Related Art Conventionally, patches having a hydrogel spread on a support such as a nonwoven fabric have been known. However, when a nonwoven fabric alone is used as a support, the patch is There was a problem that the whole became opaque and became conspicuous when the patch was applied to the skin.
【0003】一方、従来から使用されている樹脂フィル
ムは、表面が疎水性であるために、含水ゲル層との投錨
性が悪く、樹脂フィルムと含水ゲルとが剥離してしまう
ため、皮膚から貼付剤を剥がす時に含水ゲルが皮膚に残
ってしまうという問題があった。On the other hand, since the resin film which has been conventionally used has a hydrophobic surface, the anchoring property with the hydrous gel layer is poor and the resin film and the hydrous gel are separated from each other, so that the resin film is applied from the skin. There is a problem that the hydrogel remains on the skin when the agent is peeled off.
【0004】そこで、特開2000−119129号公
報には、パルプ又はレーヨンからなる繊維層と透明なフ
ィルムを積層した支持体の前記繊維層に含水ゲルを積層
することによって、支持体と含水ゲル層との投錨性を低
下させることなく、貼付時に透明感を与える化粧用ゲル
シートが記載されているが、伸縮性のあるフィルムを使
用しても、パルプやレーヨン不織布にストレッチバック
性(伸長前の形状により近付く)がないために、肌に貼
付した時、皮膚の伸縮に円滑に追随しないので突っ張り
感が強く、また伸長回復後にしわが入るため、外観上の
問題があった。Therefore, in JP-A-2000-119129, a support and a hydrous gel layer are prepared by laminating a hydrous gel on the fiber layer of a support in which a fiber layer made of pulp or rayon and a transparent film are laminated. Although a gel sheet for cosmetics that gives a transparent feeling when applied without deteriorating the anchoring property with is described, even if a stretchable film is used, stretch back properties (shape before stretching) in pulp or rayon nonwoven fabric are described. When it is applied to the skin, it does not follow the expansion and contraction of the skin smoothly, so that it has a strong feeling of tension and wrinkles are formed after the extension is recovered, which causes a problem in appearance.
【0005】本発明は、上記事情に鑑みなされたもの
で、支持体と含水ゲル層との投錨性に優れ、更に、皮膚
の伸縮によく追随して皮膚感覚を有し、かつ伸長回復後
もしわが入らず、また、良好な透明性を得ることもでき
る貼付剤を提供することを目的とする。The present invention has been made in view of the above circumstances, and is excellent in anchoring properties between a support and a hydrous gel layer, and further has a skin sensation by following the expansion and contraction of the skin well, and even after extension and recovery. It is an object of the present invention to provide an adhesive patch which does not fit into the skin and can also obtain good transparency.
【0006】[0006]
【課題を解決するための手段及び発明の実施の形態】本
発明者らは、上記課題を解決すべく鋭意検討した結果、
不織布の代わりに編布をアンカー層とすると、伸縮時に
もシワが生じない良好な貼付剤が得られることを見出
し、更に、鋭意検討を重ねた結果、上記編布を構成する
繊維の太さを特定のものとし、また、坪量を特定範囲と
すると、特に優れた含水ゲル層との投錨性が得られるこ
と、また透明化が可能になることを知見し、本発明をな
すに至った。Means for Solving the Problems and Embodiments of the Invention As a result of intensive investigations by the present inventors to solve the above problems,
It was found that when a knitted fabric is used as the anchor layer instead of the non-woven fabric, a good patch that does not cause wrinkles during expansion and contraction can be obtained, and as a result of further diligent studies, the thickness of the fibers constituting the knitted fabric was determined. The present invention has been made based on the finding that when the specific weight is set and the grammage is set in the specific range, particularly excellent anchoring property with the hydrogel layer can be obtained and transparency can be achieved.
【0007】即ち、本発明は、樹脂層と含水ゲル層との
間に編布を介在させてなることを特徴とする貼付剤を提
供する。ここで、上記編布が、5〜300デニールの単
糸若しくは15〜500デニールのマルチフィラメント
糸からなり、且つ坪量が5〜150g/m2であると、
より好適である。また、上記樹脂層が透明であると、更
に好適である。That is, the present invention provides a patch comprising a knitted fabric interposed between a resin layer and a hydrogel layer. Here, when the knitted fabric is composed of a single yarn of 5 to 300 denier or a multifilament yarn of 15 to 500 denier and has a basis weight of 5 to 150 g / m 2 ,
It is more suitable. Further, it is more preferable that the resin layer is transparent.
【0008】以下、本発明をより詳細に説明すると、本
発明の貼付剤は、樹脂層と含水ゲル層との間に編布が介
在するものである。ここで、上記樹脂層は、樹脂フィル
ムにより形成されるものであっても、後述する編布の片
面に溶融した樹脂を塗布することにより形成されるもの
であってもよい。上記樹脂としては、その種類が特に制
限されるものではないが、透明性を有する樹脂が好適で
あり、例えば、ポリエチレン(PE)、ポリプロピレン
(PP)等のオレフィン系樹脂、ポリエチレンテレフタ
レート(PET)、ポリブチレンテレフタレート(PB
T)等のエステル系樹脂、ポリエステル系ポリウレタ
ン、ポリエーテル系ポリウレタン等のウレタン系樹脂、
ナイロン12、ポリエーテルブロックアミド共重合体等
のアミド系樹脂、ポリスチレン等のスチレン系樹脂、ポ
リ塩化ビニル系樹脂、エチレン−酢酸ビニル共重合体、
ポリフルオロカーボン系樹脂等が挙げられる。これら
は、1種単独で又は2種以上をブレンドして使用するこ
とができる。なお、これらの重合度は、特に制限される
ものではなく、貼付剤の基材に通常使用されている重合
度のものを使用することができる。The present invention will be described in more detail below. In the patch of the present invention, a knitted fabric is interposed between a resin layer and a hydrogel layer. Here, the resin layer may be formed of a resin film, or may be formed by applying a molten resin to one surface of a knitted fabric described later. The type of the resin is not particularly limited, but a resin having transparency is suitable, and examples thereof include olefin resins such as polyethylene (PE) and polypropylene (PP), polyethylene terephthalate (PET), Polybutylene terephthalate (PB
T) and other ester-based resins, polyester-based polyurethanes, polyether-based polyurethanes and other urethane-based resins,
Nylon 12, amide resin such as polyether block amide copolymer, styrene resin such as polystyrene, polyvinyl chloride resin, ethylene-vinyl acetate copolymer,
Examples thereof include polyfluorocarbon-based resins. These may be used alone or in a blend of two or more. The degree of polymerization of these is not particularly limited, and those having a degree of polymerization usually used for the base material of the patch can be used.
【0009】本発明において上記透明樹脂を使用する場
合、その透明性は、特に制限されるものではないが、例
えば下記透明性(L値)が10以上、好ましくは20以
上であることが望ましい。L値が10未満であると、貼
付時に目立ってしまう場合がある。When the transparent resin is used in the present invention, its transparency is not particularly limited, but for example, the following transparency (L value) is 10 or more, preferably 20 or more. If the L value is less than 10, it may be noticeable during application.
【0010】<透明性(L値)の測定>色差計を用いて
25℃にて透過法により測定し、(L、a、b)値を求
め、L値をもって透明性を評価する。なお、測定の標準
としては(L、a、b)=(94.59、92.57、
111.43)なる特性値を有する標準白色板を用い
る。<Measurement of Transparency (L Value)> Measurement is carried out at 25 ° C. by a transmission method using a color difference meter to obtain (L, a, b) values, and the L value is used to evaluate transparency. The measurement standard is (L, a, b) = (94.59, 92.57,
A standard white plate having a characteristic value of 111.43) is used.
【0011】また、上記樹脂層の伸長回復率は、特に制
限されるものではないが、下記50%伸長回復率が縦方
向、横方向共に75%以上、好ましくは85%以上が好
適である。75%未満であると、貼付時に皮膚の伸縮に
円滑に追随しない場合がある。The elongation recovery rate of the resin layer is not particularly limited, but the following 50% elongation recovery rate is preferably 75% or more, preferably 85% or more in both the longitudinal and transverse directions. If it is less than 75%, it may not smoothly follow the expansion and contraction of the skin during application.
【0012】<50%伸長回復率>タテ(展延時の流れ
方向)、ヨコ(展延時の流れ方向に対して直角方向)両
方向に10×150mmの試料を採取し、引っ張り試験
機を用い、つかみ間隔100mm、引っ張り速度200
mm/分で50mm引き伸ばし、同速度で応力が0にな
るまで戻す。試料の初期の長さA(100mm)、引っ
張り試験後の試料の長さBをチャート紙から読み取り、
下記式より算出した。<50% elongation recovery rate> Samples of 10 × 150 mm were taken in both the vertical direction (flow direction during spreading) and the horizontal direction (direction perpendicular to the flowing direction during spreading) and gripped using a tensile tester. Distance 100 mm, pulling speed 200
Stretch 50 mm at mm / min and return at the same speed until the stress becomes zero. Read the initial length A (100 mm) of the sample and the length B of the sample after the tensile test from the chart paper,
It was calculated from the following formula.
【0013】50%伸長回復率(%)=100−(B−
A)×100/(A×0.5)
(但し、上記式中、Aは試料の初期の長さ(100m
m)、Bは引っ張り試験後の試料の長さ(mm)を表
す。)50% elongation recovery rate (%) = 100- (B-
A) × 100 / (A × 0.5) (where A is the initial length of the sample (100 m
m) and B represent the length (mm) of the sample after the tensile test. )
【0014】更に、上記樹脂層の透湿度は、好ましくは
100(g/m2・24hr)以上、より好ましくは2
00(g/m2・24hr)以上、更に好ましくは25
0(g/m2・24hr)以上であることが望ましい。
透湿度が低すぎると、貼付時にむれてしまう場合があ
る。なお、上記透湿度の上限は、特に制限されるもので
はないが、汎用性を考慮すれば、2500(g/m2・
24hr)以下、好ましくは2000(g/m2・24
hr)以下、より好ましくは1500(g/m2・24
hr)以下、更に好ましくは1000(g/m2・24
hr)以下であることが望ましい。ここで、上記透湿度
は、JIS Z 0208−1976 条件A(カップ
法)により測定することによって、確認することができ
る。Further, the water vapor permeability of the resin layer is preferably 100 (g / m 2 · 24 hr) or more, more preferably 2
00 (g / m 2 · 24 hr) or more, more preferably 25
It is preferably 0 (g / m 2 · 24 hr) or more.
If the moisture vapor transmission rate is too low, it may peel off during application. The upper limit of the water vapor transmission rate is not particularly limited, but in consideration of versatility, it is 2500 (g / m 2 ·
24 hours or less, preferably 2000 (g / m 2 · 24)
hr) or less, more preferably 1500 (g / m 2 · 24)
hr) or less, more preferably 1000 (g / m 2 · 24)
It is desirable that it is not more than hr). Here, the water vapor transmission rate can be confirmed by measuring according to JIS Z 0208-1976 condition A (cup method).
【0015】そして、上記樹脂層の厚さは、特に制限さ
れるものではないが、通常5〜100μm、特に10〜
75μmであると好適である。樹脂層の厚さが薄すぎる
と、貼付剤としての取扱い性が悪くなる場合があり、厚
すぎると、目的とする透明性、伸縮性が得られない場合
がある。なお、本発明の樹脂層が編布の片面に溶融樹脂
を塗布したものである場合、層厚さは、15〜110μ
m、特に20〜85μmが好適である。薄すぎると貼付
剤としての取扱い性が悪くなる場合があり、厚すぎると
目的とする透明性、伸縮性が得られない場合がある。The thickness of the resin layer is not particularly limited, but is usually 5 to 100 μm, particularly 10 to 10.
It is preferably 75 μm. If the thickness of the resin layer is too thin, the handleability as a patch may deteriorate, and if it is too thick, the desired transparency and stretchability may not be obtained. When the resin layer of the present invention is a knitted fabric coated with a molten resin on one side, the layer thickness is 15 to 110 μm.
m, especially 20 to 85 μm is suitable. If it is too thin, the handleability as a patch may deteriorate, and if it is too thick, the desired transparency and stretchability may not be obtained.
【0016】更に、上記樹脂層の30%モジュラスは、
特に制限されるものではないが、300g/cm以下、
好ましくは200g/cm以下、更に好ましくは100
g/cm以下であることが好ましい。300g/cmを
超えると、貼付時に皮膚の伸縮に円滑に追随しない場合
がある。なお、その下限は特に制限されないが、通常3
0g/cm以上である。Further, the 30% modulus of the resin layer is
Although not particularly limited, 300 g / cm or less,
Preferably 200 g / cm or less, more preferably 100
It is preferably g / cm or less. If it exceeds 300 g / cm, it may not smoothly follow the expansion and contraction of the skin during application. The lower limit is not particularly limited, but is usually 3
It is 0 g / cm or more.
【0017】<30%モジュラス>タテ(展延時の流れ
方向)、ヨコ(展延時の流れ方向に対して直角方向)両
方向に10×200mmの試料を採取し、引っ張り試験
機を用い、つかみ間隔150mm、引っ張り速度200
mm/分で45mm引き伸ばした時の応力を測定する。<30% Modulus> 10 × 200 mm samples were taken in both the vertical direction (flow direction at the time of spreading) and the horizontal direction (direction perpendicular to the flow direction at the time of spreading), and the gripping interval was 150 mm using a tensile tester. , Pulling speed 200
The stress when stretched 45 mm at mm / min is measured.
【0018】そしてまた、上記樹脂層(フィルム状支持
体)の粘着剤層(含水ゲル層)形成面側には必要に応じ
て、コロナ放電処理、オゾン・紫外線照射、プラズマ処
理、クロム酸処理、火炎処理、熱風処理、表面の凸凹処
理等が施されてもよい。If necessary, a corona discharge treatment, ozone / ultraviolet irradiation, plasma treatment, chromic acid treatment, or the like may be performed on the pressure-sensitive adhesive layer (hydrogel layer) forming side of the resin layer (film-like support). Flame treatment, hot air treatment, surface irregularity treatment, etc. may be performed.
【0019】本発明の貼付剤は、上記樹脂層の粘着剤層
形成面側に編布を設けたものであり、編布は、不織布、
織布と比較して、タテ・ヨコ共に、伸展後のストレッチ
バック性に優れ、肌に貼付した時、皮膚の伸縮に円滑に
追随するので、突っ張り感がなく、皮膚感覚を有するこ
とができるものである。The patch of the present invention comprises a knitted fabric provided on the pressure-sensitive adhesive layer forming surface side of the above resin layer, and the knitted fabric is a non-woven fabric,
Compared to woven cloth, both vertical and horizontal have excellent stretch back properties after extension, and when attached to the skin, they smoothly follow the expansion and contraction of the skin, so there is no feeling of tension and a skin feeling. Is.
【0020】本発明の編布は、繊維の素材(種類)は特
に限定されず、例えば、ポリエステル、ナイロン、ポリ
オレフィン(PE,PP等)、ビニロン、ポリ塩化ビニ
リデン、ポリ塩化ビニル、アクリル樹脂、ポリウレタン
等の樹脂等が挙げられる。なお、これらの重合度は、特
に制限されるものではなく、編布の素材として通常使用
されている重合度のものを使用することができる。The knitted fabric of the present invention is not particularly limited in fiber material (type), and examples thereof include polyester, nylon, polyolefin (PE, PP, etc.), vinylon, polyvinylidene chloride, polyvinyl chloride, acrylic resin, polyurethane. And the like. The degree of polymerization of these is not particularly limited, and those having a degree of polymerization usually used as a knitted fabric material can be used.
【0021】本発明の編布の編み方は、特に制限される
ものではなく、例えば経編み(トリコット編み、デンビ
ートリコット編み、サテン編み、アトラス編み、平編
み、リム編み、パール編み)、丸編み(両面メリヤス編
み、片面メリヤス編み、フライスメリヤス編み)、横編
み、マルチフィラメント糸により編成された丸編み、複
数段の両面メリヤス編み、ニットミス編み、クロスイン
レイ編み、インレイ編み等が採用される。好ましくは、
トリコット編み、両面メリヤス編み、片面メリヤス編
み、フライスメリヤス編み、マルチフィラメント糸によ
り編成された丸編み、複数段の両面メリヤス編みが採用
される。The knitting method of the knitted fabric of the present invention is not particularly limited, for example, warp knitting (tricot knitting, denby tricot knitting, satin knitting, atlas knitting, plain knitting, rim knitting, pearl knitting), circular knitting (Double-sided knitting, single-sided knitting, fraise-knitting), weft knitting, circular knitting made of multifilament yarn, multi-step double-sided knitting, miss-knitting, cross-inlay knitting, inlay knitting, etc. are used. Preferably,
Tricot knitting, double-sided knitting, single-sided knitting, milling knitting, circular knitting made of multifilament yarn, and multi-step double-sided knitting are used.
【0022】本発明の編布の繊維の太さは、単糸を使用
する場合、5〜300デニール、好ましくは15〜15
0デニールが好適である。5デニール未満であると、樹
脂層と含水ゲルが投錨しない場合がある。300デニー
ルを超えると、繊維とその周囲とのコントラストが大き
く、繊維が目立つ場合がある。The fiber thickness of the knitted fabric of the present invention is 5 to 300 denier, preferably 15 to 15 when a single yarn is used.
0 denier is preferred. If it is less than 5 denier, the resin layer and the hydrogel may not anchor. When it exceeds 300 denier, the contrast between the fiber and the surrounding area is large, and the fiber may be conspicuous.
【0023】また、マルチフィラメント糸を使用する場
合、15〜500デニール、好ましくは30〜300デ
ニールが好適である。15デニール未満であると、樹脂
層と含水ゲルが投錨しない場合がある。500デニール
を超えると、繊維とその周囲とのコントラストが大き
く、繊維が目立つ場合がある。When multifilament yarn is used, it is preferably 15 to 500 denier, preferably 30 to 300 denier. If it is less than 15 denier, the resin layer and the hydrogel may not anchor. When it exceeds 500 denier, the contrast between the fiber and its surroundings is large, and the fiber may be conspicuous.
【0024】また、本発明の編布の坪量は、下限が5g
/m2以上、好ましくは10g/m2以上、より好ましく
は20g/m2以上が好適である。5g/m2未満である
と、樹脂層と含水ゲルが投錨しない場合がある。上限は
150g/m2以下、好ましくは80g/m2以下、更に
好ましくは60g/m2以下が好適である。150g/
m2を超えると、貼付剤全体の透明性が得られない場合
がある。The lower limit of the basis weight of the knitted fabric of the present invention is 5 g.
/ M 2 or more, preferably 10 g / m 2 or more, more preferably 20 g / m 2 or more. If it is less than 5 g / m 2 , the resin layer and the hydrogel may not anchor. The upper limit is 150 g / m 2 or less, preferably 80 g / m 2 or less, and more preferably 60 g / m 2 or less. 150 g /
When it exceeds m 2 , the transparency of the entire patch may not be obtained in some cases.
【0025】更に、本発明の編布の伸長回復率は、上記
50%伸長回復率が縦方向で70%以上、好ましくは8
0%以上、横方向で75%以上、好ましくは85%以上
であると好適である。低すぎると、貼付時に皮膚の伸縮
に円滑に追随しない場合がある。Further, the elongation recovery rate of the knitted fabric of the present invention is such that the 50% elongation recovery rate is 70% or more in the machine direction, preferably 8%.
It is preferably 0% or more, 75% or more in the lateral direction, and preferably 85% or more. If it is too low, it may not smoothly follow the expansion and contraction of the skin during application.
【0026】上記編布の30%モジュラスは、特に制限
されるものではないが、300g/cm以下、好ましく
は200g/cm以下、更に好ましくは100g/cm
以下であることが好ましい。300g/cmを超える
と、貼付時に皮膚の伸縮に円滑に追随しない場合があ
る。なお、その下限は特に制限されないが、通常30g
/cm以上である。The 30% modulus of the knitted fabric is not particularly limited, but is 300 g / cm or less, preferably 200 g / cm or less, more preferably 100 g / cm.
The following is preferable. If it exceeds 300 g / cm, it may not smoothly follow the expansion and contraction of the skin during application. The lower limit is not particularly limited, but is usually 30 g.
/ Cm or more.
【0027】本発明の貼付剤は、上記樹脂層と上記編布
との積層体を支持体とするものであり、該支持体の製造
方法は、特に制限されるものではないが、例えば上記樹
脂のフィルムを上記編布に熱溶着する方法、又は適宜接
着剤等を用いて積層する方法、溶融した上記樹脂を上記
編布の片面に塗布、乾燥して該編布の一面に樹脂層を形
成する方法などによって製造することができる。The patch of the present invention uses a laminate of the above resin layer and the above knitted fabric as a support, and the method for producing the support is not particularly limited, but for example, the above resin may be used. Method of heat-welding the film to the knitted fabric, or a method of laminating it using an adhesive or the like as appropriate, the molten resin is applied to one side of the knitted fabric and dried to form a resin layer on one side of the knitted fabric. It can be manufactured by a method such as.
【0028】上記樹脂層と上記編布との積層体の伸長回
復率は、上記伸長回復率が縦方向で70%以上、好まし
くは80%以上、横方向で75%以上、好ましくは85
%以上であると好適である。低すぎると、貼付時に皮膚
の伸縮に円滑に追随しない場合がある。The elongation recovery rate of the laminate of the resin layer and the knitted fabric is 70% or more in the machine direction, preferably 80% or more in the machine direction, and 75% or more in the machine direction, preferably 85.
% Or more is preferable. If it is too low, it may not smoothly follow the expansion and contraction of the skin during application.
【0029】上記樹脂層と上記編布との積層体の30%
モジュラスは、特に制限されるものではないが、300
g/cm以下、好ましくは200g/cm以下、更に好
ましくは100g/cm以下であることが好ましい。3
00g/cmを超えると、貼付時に皮膚の伸縮に円滑に
追随しない場合がある。なお、その下限は特に制限され
ないが、通常30g/cm以上である。30% of the laminate of the resin layer and the knitted fabric
The modulus is not particularly limited, but is 300
It is preferably g / cm or less, preferably 200 g / cm or less, and more preferably 100 g / cm or less. Three
If it exceeds 00 g / cm, it may not smoothly follow the expansion and contraction of the skin during application. The lower limit is not particularly limited, but is usually 30 g / cm or more.
【0030】本発明の貼付剤の含水ゲルとしては、ポリ
アクリル酸及び/又はポリアクリル酸塩を含有するマト
リックスに多価金属塩などの架橋剤を添加してゲル化し
た含水系ゲルが好適である。更に、他の高分子化合物を
マトリックス基材に配合すると、使用感がよい粘着剤
(含水ゲル)が得られるので、より好ましい。The water-containing gel of the patch of the present invention is preferably a water-containing gel obtained by adding a crosslinking agent such as a polyvalent metal salt to a matrix containing polyacrylic acid and / or polyacrylic acid salt to form a gel. is there. Furthermore, it is more preferable to add another polymer compound to the matrix substrate, because an adhesive (hydrous gel) having a good feeling in use can be obtained.
【0031】上記ポリアクリル酸としてはいずれのもの
でも使用でき、その分子量及び直鎖状、分岐鎖状等の形
状には特に制限はないが、重量平均分子量1万〜100
0万のものを用いることが好ましく、特に重量平均分子
量が1万〜50万未満、50万〜200万未満、200
万〜700万の平均分子量を有するポリアクリル酸及び
その塩を2種以上組み合わせると、使用感が向上するの
で好適である。なお、通常のアクリル酸を重合して得ら
れた重合体のほか、カルボキシビニルポリマー、例えば
カーボポール(商品名:米国グッドリッチ社製)等のア
クリル酸重合体を一部架橋したものも好適に使用し得
る。Any of the above polyacrylic acids can be used, and its molecular weight and linear or branched shape are not particularly limited, but the weight average molecular weight is from 10,000 to 100.
It is preferable to use those having a weight average molecular weight of 10,000 to less than 500,000, 500,000 to less than 2,000,000, and 200 to 200,000.
It is preferable to combine two or more kinds of polyacrylic acid having an average molecular weight of 10,000 to 7,000,000 and salts thereof, since the feeling of use is improved. In addition to a polymer obtained by polymerizing ordinary acrylic acid, a partially crosslinked acrylic acid polymer such as carboxyvinyl polymer, for example, Carbopol (trade name: manufactured by Goodrich, USA) is also suitable. Can be used.
【0032】また、ポリアクリル酸塩としてはポリアク
リル酸ナトリウム、ポリアクリル酸カリウム等のポリア
クリル酸の一価金属塩、ポリアクリル酸モノエタノール
アミン、ポリアクリル酸ジエタノールアミン、ポリアク
リル酸トリエタノールアミン等のポリアクリル酸のアミ
ン塩、ポリアクリル酸のアンモニウム塩等の1種又は2
種以上が好適に使用し得る。As the polyacrylic acid salt, monovalent metal salts of polyacrylic acid such as sodium polyacrylate and potassium polyacrylate, monoethanolamine polyacrylate, diethanolamine polyacrylate, triethanolamine polyacrylate, etc. 1 or 2 such as amine salt of polyacrylic acid and ammonium salt of polyacrylic acid
More than one species may be preferably used.
【0033】ポリアクリル酸及び/又はポリアクリル酸
塩の配合量は、含水ゲル全体の1〜20質量%、特に3
〜15質量%とすることが好ましい。配合量が少なすぎ
ると投錨力が不足する場合があり、多すぎると含水系ゲ
ルの粘度が高くなり、製造時の作業性に問題が生じた
り、貼付剤を剥がす時に痛みを感じる場合がある。The amount of polyacrylic acid and / or polyacrylic acid salt compounded is 1 to 20% by mass, especially 3% by mass of the total hydrogel.
It is preferable to set it to -15 mass%. If the blending amount is too small, the anchoring force may be insufficient, and if the blending amount is too large, the viscosity of the water-containing gel may be high, which may cause a problem in workability during production or may cause pain when peeling the patch.
【0034】上記多価金属塩とは、水溶液中で多価金属
イオンを放出するものであり、多価金属塩としては、金
属と架橋する水溶性高分子化合物を金属架橋し得る限
り、その種類は、特に制限されるものではなく、例えば
マグネシウム化合物、カルシウム化合物、亜鉛化合物、
カドミウム化合物、アルミニウム化合物、チタン化合
物、錫化合物、鉄化合物、クロム化合物、マンガン化合
物、コバルト化合物、ニッケル化合物等が使用し得る
が、本発明の貼付剤は皮膚に適用するものであり、皮膚
に対する安全性を考慮するならば、アルミニウム化合
物、マグネシウム化合物、カルシウム化合物等を用いる
ことが特に好ましい。The polyvalent metal salt is a salt that releases polyvalent metal ions in an aqueous solution, and as the polyvalent metal salt, as long as a water-soluble polymer compound that crosslinks with a metal can be crosslinked with a metal, Is not particularly limited, for example magnesium compound, calcium compound, zinc compound,
Cadmium compounds, aluminum compounds, titanium compounds, tin compounds, iron compounds, chromium compounds, manganese compounds, cobalt compounds, nickel compounds and the like can be used, but the patch of the present invention is applied to the skin and is safe for the skin. Considering the properties, it is particularly preferable to use an aluminum compound, a magnesium compound, a calcium compound or the like.
【0035】この場合、アルミニウム化合物、マグネシ
ウム化合物及びカルシウム化合物はいずれのものも好適
に使用し得、例えばカリウムミョウバン、アンモニウム
ミョウバン、鉄ミョウバン等のミョウバン類、水酸化ア
ルミニウム、硫酸アルミニウム、塩化アルミニウム、ア
ルミニウムグリシネート、酢酸アルミニウム、酸化アル
ミニウム、含ケイ酸アルミニウム、メタケイ酸アルミニ
ウム、水酸化カルシウム、炭酸カルシウム、硫酸カルシ
ウム、硝酸カルシウム、塩化カルシウム、酢酸カルシウ
ム、酸化カルシウム、リン酸カルシウム、水酸化マグネ
シウム、炭酸マグネシウム、硫酸マグネシウム、酢酸マ
グネシウム、ケイ酸マグネシウム、酸化マグネシウム、
水酸化アルミナマグネシウム、メタケイ酸アルミン酸マ
グネシウム、ケイ酸アルミン酸マグネシウム、合成ヒド
ロタルサイト、これら金属を含む複塩等の水可溶性化合
物、水難溶性化合物の1種又は2種以上を使用し得る。
また、アルミニウム、マグネシウムを含む制酸剤も多価
金属塩として配合し得る。In this case, any of aluminum compounds, magnesium compounds and calcium compounds can be preferably used, and examples thereof include alums such as potassium alum, ammonium alum, iron alum, aluminum hydroxide, aluminum sulfate, aluminum chloride and aluminum. Glycinate, aluminum acetate, aluminum oxide, aluminum silicate, aluminum metasilicate, calcium hydroxide, calcium carbonate, calcium sulfate, calcium nitrate, calcium chloride, calcium acetate, calcium oxide, calcium phosphate, magnesium hydroxide, magnesium carbonate, sulfuric acid Magnesium, magnesium acetate, magnesium silicate, magnesium oxide,
One or more of water-soluble compounds such as magnesium hydroxide aluminate, magnesium aluminometasilicate, magnesium aluminate silicate, synthetic hydrotalcite, double salts containing these metals, and poorly water-soluble compounds may be used.
In addition, an antacid containing aluminum or magnesium may be added as a polyvalent metal salt.
【0036】ここで、上記多価金属塩を配合する場合、
その配合量は、その種類により種々異なり、特に制限さ
れるものではないが、含水ゲル全体の0.001〜10
質量%、特に0.01〜5質量%とすることが好まし
い。Here, when the polyvalent metal salt is blended,
The blending amount varies depending on the kind, and is not particularly limited, but 0.001 to 10 of the whole hydrogel.
It is preferable to set the content by mass%, particularly 0.01 to 5% by mass.
【0037】更に、その他の水溶性高分子化合物を配合
する場合、その種類は特に制限されず、従来より使用さ
れているものを使用することができる。例えばゼラチ
ン、カンテン、ポリビニルアルコール、ポリビニルピロ
リドンポリエチレンオキサイド、カルボキシメチルセル
ロース、カルボキシメチルセルロースナトリウム、ヒド
ロキシプロピルセルロース、ヒドロキシエチルセルロー
ス、メチルセルロース、アルギン酸ナトリウム、キサン
タンガム、アラビアガム、トラガントガム、カラヤガ
ム、無水マレイン酸共重合体、プロピレングリコール、
カルボキシメチルスターチナトリウム、カラギーナン等
が挙げられる。これらは1種単独で又は2種以上を適宜
組み合わせて使用することができるが、本発明の場合、
特にカルボキシメチルセルロースナトリウムを上記ポリ
アクリル酸及び/又はポリアクリル酸塩に混合し、更
に、必要に応じて他の高分子化合物を混合して用いるこ
とが望ましい。なお、これら他の水溶性高分子化合物の
配合量は、本発明の含水ゲルの透明性を損なわない範囲
で適宜選定することができる。Further, when other water-soluble polymer compound is blended, the kind thereof is not particularly limited, and those conventionally used can be used. For example, gelatin, agar, polyvinyl alcohol, polyvinylpyrrolidone polyethylene oxide, carboxymethyl cellulose, carboxymethyl cellulose sodium, hydroxypropyl cellulose, hydroxyethyl cellulose, methyl cellulose, sodium alginate, xanthan gum, gum arabic, tragacanth gum, karaya gum, maleic anhydride copolymer, propylene glycol. ,
Examples include carboxymethyl starch sodium and carrageenan. These may be used alone or in combination of two or more, but in the case of the present invention,
In particular, it is desirable to mix sodium carboxymethyl cellulose with the above polyacrylic acid and / or polyacrylic acid salt, and further to mix and use other polymer compounds, if necessary. The amount of these other water-soluble polymer compounds to be compounded can be appropriately selected within a range that does not impair the transparency of the hydrogel of the present invention.
【0038】本発明の含水系ゲルには、必要に応じて他
の成分を任意に配合しても差し支えない。例えば、薬効
成分、温感付与成分、乳化剤、保湿成分(多価アルコー
ル)、清涼化剤、無機粉体、防腐剤、香料、色素等を配
合することができる。The water-containing gel of the present invention may optionally contain other components, if desired. For example, a medicinal component, a warming sensation-imparting component, an emulsifier, a moisturizing component (polyhydric alcohol), a refreshing agent, an inorganic powder, an antiseptic, a fragrance, a pigment, etc. can be added.
【0039】より具体的には、薬効成分として、例えば
インドメタシン、サリチル酸グリコール、サリチル酸メ
チル、ケトプロフェン、フルルビプロフェン、イブプロ
フェン、スプロフェン、ロキソプロフェン、ザルトプロ
フェン、ピロキシカム、フェルビナク、ジフェンヒドラ
ミン、ジブカイン、プロカイン、リドカイン、ビタミン
E誘導体、グリチルレチン酸あるいはこれらの誘導体等
が挙げられ、これらは1種単独で又は2種類以上を適宜
組み合わせて使用することができる。More specifically, the medicinal properties include, for example, indomethacin, glycol salicylate, methyl salicylate, ketoprofen, flurbiprofen, ibuprofen, suprofen, loxoprofen, zaltoprofen, piroxicam, felbinac, diphenhydramine, dibucaine, procaine, lidocaine, vitamins. Examples thereof include E derivatives, glycyrrhetinic acid and derivatives thereof, and these can be used alone or in combination of two or more kinds as appropriate.
【0040】上記温感付与成分としては、カプサイシノ
イド,カプサイシン,ジヒドロキシカプサイシン、カプ
サンチンなどのカプサイシン類似体,カプシコシド,ト
ウガラシエキス,トウガラシチンキ,トウガラシ末等の
トウガラシ由来物質、ニコチン酸ベンジル、ニコチン酸
β−ブトキシエチル、N−アシルワニルアミド、ノニル
酸ワニルアミド、及び下記一般式(1)で表わされるバ
ニリルアルコールアルキルエーテルであり、これら1種
を単独で又は2種以上を適宜組み合わせて使用すること
ができる。Examples of the above-mentioned ingredients for imparting warmth include capsaicinoid, capsaicin, dihydroxycapsaicin, capsaicin analogues such as capsanthin, capsicoside, capsicum extract, capsicum tincture, capsicum-derived substances such as capsicum, benzyl nicotinate, β-butoxy nicotinate. Ethyl, N-acyl vanilamide, nonyl acid vanilamide, and vanillyl alcohol alkyl ether represented by the following general formula (1), which can be used alone or in combination of two or more kinds. .
【0041】[0041]
【化1】 (式中、R=炭素数1〜6のアルキル基)[Chemical 1] (In the formula, R is an alkyl group having 1 to 6 carbon atoms)
【0042】本発明の含水ゲルに対する上記温感付与物
質の配合量(2種以上併用の場合は合計配合量)は、含
水ゲル全体の0.0001〜5質量%が好適であり、よ
り好ましくは0.001〜3質量%、更に好ましくは
0.005〜1質量%である。上記温感付与物質の配合
量が少なすぎると十分な温感が付与されない場合があ
り、多すぎると皮膚刺激性を生じる場合がある。The blending amount of the above-mentioned warming sensation-imparting substance with respect to the hydrous gel of the present invention (total blending amount when two or more kinds are used in combination) is preferably 0.0001 to 5 mass% of the entire hydrous gel, and more preferably. The amount is 0.001 to 3% by mass, and more preferably 0.005 to 1% by mass. If the blending amount of the warming sensation-imparting substance is too small, sufficient warmth may not be imparted, and if it is too large, skin irritation may occur.
【0043】乳化剤としては、例えばジグリセリンモノ
ステアレート等のポリグリセリン脂肪酸エステル、ポリ
オキシエチレン(POE)(10)グリセリルモノオレ
エート等のポリオキシエチレングリセリン脂肪酸エステ
ル、ポリオキシエチレン脂肪酸エステル、POE(2
5)ラウリルエーテル等のポリオキシエチレンアルキル
エーテル,ポリオキシエチレンポリオキシプロピレンア
ルキルエーテルなどのポリオキシアルキレンアルキルエ
ーテル、ポリオキシエチレンアルキルエーテル硫酸(エ
ステル)塩、脂肪酸石けん、ソルビタン脂肪酸エステ
ル、グリセリン脂肪酸エステル、ポリオキシエチレンソ
ルビタン脂肪酸エステル、ポリオキシエチレン硬化ヒマ
シ油、アルキル硫酸塩、N−アシルメチルタウリン塩、
アルキルアンモニウム塩、酢酸ベタイン、プロピレング
リコール脂肪酸エステル、ビタミン誘導体、グリチルリ
チン酸,グリチルレチン酸及びこれらの誘導体等が挙げ
られ、具体的にはソルビタンモノオレート、グリセリル
モノオレート、デカグリセリルモノオレート、ジグリセ
リルジオレート、ヘキサグリセリルモノラウレート、プ
ロピレングリコールモノステアレート、POE(20)
ソルビタンモノオレート、POE(60)ソルビットテ
トラオレート、POE(40)モノステアレート、PO
E(10)オレイルエーテル、POE(10)ノニルフ
ェニルエーテル、POE(50)硬化ヒマシ油、POE
(5)オレイン酸アミド、ラウリル硫酸ナトリウム、P
OEアルキルエーテル硫酸ナトリウム、POEアルキル
エーテル酢酸ナトリウム、トリPOE(10)アルキル
エーテルリン酸、塩化ステアリルトリメチルアンモニウ
ム、塩化ベンザルコニウム、ラウリルジメチルアミノ酢
酸ベタイン、卵黄、レシチン、イミダゾリニウムベタイ
ン、セバシン酸ジエチル等が挙げられる。Examples of the emulsifier include polyglycerin fatty acid ester such as diglycerin monostearate, polyoxyethylene (POE) (10) polyoxyethylene glycerin fatty acid ester such as glyceryl monooleate, polyoxyethylene fatty acid ester, POE ( Two
5) Polyoxyethylene alkyl ether such as lauryl ether, polyoxyalkylene alkyl ether such as polyoxyethylene polyoxypropylene alkyl ether, polyoxyethylene alkyl ether sulfuric acid (ester) salt, fatty acid soap, sorbitan fatty acid ester, glycerin fatty acid ester, Polyoxyethylene sorbitan fatty acid ester, polyoxyethylene hydrogenated castor oil, alkyl sulfate, N-acylmethyl taurine salt,
Examples thereof include alkylammonium salt, betaine acetate, propylene glycol fatty acid ester, vitamin derivative, glycyrrhizic acid, glycyrrhetinic acid and derivatives thereof, and specifically, sorbitan monooleate, glyceryl monooleate, decaglyceryl monooleate, diglyceryl dioleate. , Hexaglyceryl monolaurate, propylene glycol monostearate, POE (20)
Sorbitan monooleate, POE (60) sorbit tetraoleate, POE (40) monostearate, PO
E (10) oleyl ether, POE (10) nonylphenyl ether, POE (50) hydrogenated castor oil, POE
(5) Oleic acid amide, sodium lauryl sulfate, P
Sodium OE alkyl ether sulfate, Sodium POE alkyl ether acetate, Tri-POE (10) alkyl ether phosphate, Stearyl trimethyl ammonium chloride, Benzalkonium chloride, Betaine lauryl dimethylaminoacetate, Egg yolk, Lecithin, Imidazolinium betaine, Diethyl sebacate Etc.
【0044】上記保湿成分(多価アルコール)として
は、グリセリン、ソルビトール、エチレングリコール、
プロピレングリコール、ポリエチレングリコール、ポリ
プロピレングリコール、1,3−プロパンジオール、
1,4−ブタンジオール、マルチトール、キシリトール
等が挙げられ、これらは1種単独で又は2種類以上を適
宜組み合わせて使用することができる。As the moisturizing component (polyhydric alcohol), glycerin, sorbitol, ethylene glycol,
Propylene glycol, polyethylene glycol, polypropylene glycol, 1,3-propanediol,
1,4-butanediol, maltitol, xylitol and the like can be mentioned, and these can be used alone or in an appropriate combination of two or more kinds.
【0045】上記清涼化剤としては、カンフル、チモー
ル、メントール、N−エチル−p−メンタン−カルボキ
シアミド、p−メンタン−3,8−ジオール、l−イソ
プレゴール、l−メンチルグリセリルエーテル等のメン
トール誘導体などが挙げられ、これらは1種単独で又は
2種類以上を適宜組み合わせて使用することができる。As the above-mentioned cooling agent, menthol derivatives such as camphor, thymol, menthol, N-ethyl-p-menthane-carboxamide, p-menthane-3,8-diol, 1-isopulegol and 1-menthylglyceryl ether are used. And the like. These can be used alone or in combination of two or more kinds as appropriate.
【0046】上記無機粉体としては、スメクタイト、カ
オリン、酸化亜鉛、酸化チタン、無水ケイ酸等が挙げら
れ、これらは1種単独で又は2種類以上を適宜組み合わ
せて使用することができる。Examples of the above-mentioned inorganic powder include smectite, kaolin, zinc oxide, titanium oxide, silicic acid anhydride, etc. These can be used alone or in combination of two or more kinds.
【0047】上記防腐剤としては、メチルパラベン、プ
ロピルパラベン、チモール等が挙げられ、これらは1種
単独で又は2種類以上を適宜組み合わせて使用すること
ができる。Examples of the above preservatives include methylparaben, propylparaben, thymol, etc. These can be used alone or in combination of two or more kinds.
【0048】香料としては、例えばウイキョウ油、ヒマ
シ油、ハッカ油、ハッカハク油、ダイウイキョウ油、ケ
イヒ油、チョウジ油、チミアン油、テレビン油、ヘノポ
ジ油、ヤマジン油、ユーカリ油、ラベンダー油、レモン
油、オレンジ油、トウカ油、ベルガモット油、ローズ
油、シトロネラ油、レモングラス油、樟脳油、ゼラニウ
ム油等が挙げられる。また、植物抽出物としては、例え
ばアロエ、アニス、アンジェリカ、安息香、イモーテ
ル、カミツレ、カモミール、ガーリック、カルダモン、
ガルバナム、キャラウェイ、キャロットシード、グアヤ
ックウッド、グレープフルーツ、サイプレス、サンダル
ウッド、シダーウッド、ジュニパー、スターアニス、セ
ージ、ゼラニウム、セロリ、タイム、タラゴン、テレビ
ン、乳香、バイオレット、パイン、パセリ、バーチ、パ
チュリー、バラ、ヒソップ、フェンネル、ブラックペッ
パー、ボダイジュ花、没薬、ヤロウ、レモン、レモング
ラス、ローズマリー、ローレル、シモツケギク、シモツ
ケソウ、ヤグルマギク、アーモンド、アザミ、アルニ
カ、イトスギ、ウイキョウ、エニシダ、エリカ、オオグ
ルマ、カラシ、カロコン、カンズイ、キクニガナ、ギョ
ウギシバ、キンセンカ、クサノオウ、クレソン、ゲン
カ、ゲンチアナ、サリランボ、シカゼンシ、シラカバ、
シダ、シツリシ、ショウノウ、ショウリク、ジンギョ
ウ、スモモ、セイヨウナシ、セイヨウヒメスノキ、タイ
ソウ、タクシャ、タンポポ、チモ、チャービル、チョレ
イ、テンモンドウ、トウガシ、ノイバラ、ノラニンジ
ン、ハゴロモグサ、ハッカ、トネリコ、ヒメオドリコソ
ウ、ヒメスイバ、ブクリョウ、ボリジ、マグワート、マ
ヨラナ、メリッサ、モクツウ、モモ、ヤドリギ、ユーカ
リ、ヨクイニン、ラベンダー、レンギョウ、ワサビダイ
コン等からの抽出物を挙げることができるが、これらの
中でも、特にカモミール、セージ、パセリ、ローズマリ
ー、シモツケギク、シモツケソウ、ヤグルマギク、アニ
ス、ローレル、アンジェリカ、フェンネル、ハッカ(ペ
パーミント、レモンバーム)、ラベンダー、タイム等か
らの抽出物が好適であり、このような抽出物の具体的な
成分として、例えば、モノテルペン炭化水素、シネオー
ル、ボルネオール、他にカンファー(樟脳)、リナノー
ル、ベルベノール、フラボノイド類、コリン、アミノ
酸、タンニン、植物酸、脂肪酸、青酸配糖体、サリチル
酸誘導体、サルビン、縮合タンニン、フェノール酸、カ
ルノシン酸、トリテルペン酸、ツヨン、サルベン、ピネ
ン、アピオール、アピオリン、ミリスチシン、クマリ
ン、カマアズレン、ファルネセン、ビサボロール、ゲラ
ニオール、オイゲノール、テルペン、フェランドリン、
アネトール、メントール、メントン、リモネン、シトラ
ール、シトロネラール、オイゲノールアセテート等を挙
げることができる。Examples of the fragrance include fennel oil, castor oil, peppermint oil, peppermint oil, daisy leaf oil, cinnamon oil, clove oil, thymian oil, turpentine oil, henoposite oil, yamazine oil, eucalyptus oil, lavender oil, lemon oil, Orange oil, toka oil, bergamot oil, rose oil, citronella oil, lemongrass oil, camphor oil, geranium oil and the like can be mentioned. Further, as the plant extract, for example, aloe, anise, angelica, benzoin, immortelle, chamomile, chamomile, garlic, cardamom,
Galvanum, caraway, carrot seed, guaiac wood, grapefruit, cypress, sandalwood, cedarwood, juniper, star anise, sage, geranium, celery, thyme, tarragon, turpentine, frankincense, violet, pine, parsley, birch, patchouli, rose , Hyssop, Fennel, Black pepper, Bodaiju flower, Myrrh, Yarrow, Lemon, Lemongrass, Rosemary, Laurel, Spiraea, Spiraea, Cornflower, Almond, Thistle, Arnica, Cypress, Fennel, Enishida, Erica, Oguruma, mustard, calocon , Kanzui, yellow clover, ginkgo biloba, calendula, celandine, watercress, genka, gentian, sari ambo, sycamore, birch,
Fern, shirushi, camphor, chopsticks, syringa, plum, pear, halibut, taiso, takusha, dandelion, chimo, chervil, chorei, tenmondou, capsicum, neura, norangin, hagomogusa, mint, sycamore, sycamore, sycamore, sycamore. Extracts from bukuro, borigi, magwort, mayorana, melissa, mokutou, peach, mistletoe, eucalyptus, yokuinin, lavender, forsythia, wasabi radish and the like can be mentioned, but among these, especially chamomile, sage, parsley, rose. Extracts from marie, syringa, syringa, cornflower, anise, laurel, angelica, fennel, peppermint (peppermint, lemon balm), lavender, thyme, etc. are suitable. As specific components of such extract, for example, monoterpene hydrocarbon, cineole, borneol, camphor (camphor), linanol, berbenol, flavonoids, choline, amino acid, tannin, vegetable acid, fatty acid, hydrocyanic acid Glycoside, salicylic acid derivative, salvin, condensed tannin, phenolic acid, carnosic acid, triterpene acid, thujong, salben, pinene, apiol, apioline, myristicin, coumarin, kamaazulen, farnesene, bisabolol, geraniol, eugenol, terpene, ferrandrin,
Examples thereof include anethole, menthol, menthone, limonene, citral, citronellal and eugenol acetate.
【0049】色素としては、その種類は特に限定され
ず、法定色素ハンドブック記載の色素を配合することが
できる。The type of dye is not particularly limited, and dyes described in the Legal Dye Handbook can be blended.
【0050】また、本発明の含水ゲル層は、含水系であ
り、その含水率は、特に制限されるものではないが、最
終組成物100質量部あたりの含水率は、30〜98質
量部、より好ましくは40〜95質量部が望ましい。含
水率が低すぎると支持体と含水ゲル層との投錨性が悪く
なる場合があり、高すぎると粘着ゲルとしての物性が得
られない場合がある。The water-containing gel layer of the present invention is a water-containing system, and the water content is not particularly limited, but the water content per 100 parts by weight of the final composition is 30 to 98 parts by weight, More preferably, 40 to 95 parts by mass is desirable. If the water content is too low, the anchorability between the support and the water-containing gel layer may be poor, and if it is too high, the physical properties as an adhesive gel may not be obtained.
【0051】本発明の貼付剤は、上記支持体に上記含水
ゲルを展延したものであり、展延する含水ゲル量(膏体
量)は、特に制限されるものではないが、通常、1〜4
0(g/10×14cm)、好ましくは1〜30(g/
10×14cm)が望ましい。展延量が多すぎると、透
明性(L値)を確保することが困難となる場合がある。The patch of the present invention is obtained by spreading the hydrous gel on the support, and the amount of hydrous gel (the amount of paste) to be spread is not particularly limited, but usually 1 ~ 4
0 (g / 10 x 14 cm), preferably 1 to 30 (g /
10 × 14 cm) is desirable. If the spread amount is too large, it may be difficult to secure transparency (L value).
【0052】本発明の貼付剤の製造法は、特に制限され
るものではなく、例えば上記含水ゲル層の組成成分を公
知の方法にて練り合わせて含水ゲルを調製し、この含水
ゲルを上記支持体の編布側に均一に展延することによっ
て含水ゲル層を得、更に、プラスチックフイルムで含水
ゲル層表面(膏体面)を覆い、適当な大きさに裁断し、
貼付剤とすることができる。The method for producing the patch of the present invention is not particularly limited. For example, the composition components of the hydrogel layer are kneaded by a known method to prepare a hydrogel, and the hydrogel is used as the support. The water-containing gel layer is obtained by uniformly spreading on the knitted fabric side, and the surface of the water-containing gel layer (paste surface) is covered with a plastic film and cut into an appropriate size.
It can be a patch.
【0053】本発明の貼付剤(含水ゲル層表面を覆って
いる剥離フィルムとしてのプラスチックフィルムは剥離
した状態)の伸長回復率は、上記伸長回復率が縦方向で
65%以上、好ましくは75%以上、横方向で70%以
上、好ましくは80%以上であると好適である。低すぎ
ると、貼付時に皮膚の伸縮に円滑に追随しない場合があ
る。The extension recovery rate of the patch of the present invention (in the state where the plastic film as the release film covering the surface of the hydrous gel layer is released) is 65% or more, preferably 75%, in the longitudinal direction. As described above, it is preferably 70% or more, preferably 80% or more in the lateral direction. If it is too low, it may not smoothly follow the expansion and contraction of the skin during application.
【0054】本発明の貼付剤(含水ゲル層表面を覆って
いる剥離フィルムとしてのプラスチックフィルムは剥離
した状態)の30%モジュラスは、特に制限されるもの
ではないが、350g/cm以下、好ましくは250g
/cm以下、更に好ましくは150g/cm以下である
ことが好ましい。350g/cmを超えると、貼付時に
皮膚の伸縮に円滑に追随しない場合がある。なお、その
下限は特に制限されないが、通常60g/cm以上であ
る。The 30% modulus of the patch of the present invention (in which the plastic film as the release film covering the surface of the hydrous gel layer is peeled off) is not particularly limited, but it is 350 g / cm or less, preferably 250 g
/ Cm or less, more preferably 150 g / cm or less. If it exceeds 350 g / cm, it may not smoothly follow the expansion and contraction of the skin during application. The lower limit is not particularly limited, but is usually 60 g / cm or more.
【0055】本発明の貼付剤の投錨性は、特に制限され
るものではないが、後述する実施例に記載した投錨性の
測定方法によって投錨性(皮膚への残存率)を測定した
時、10%以下、特に5%以下であることが望ましい。
上記残存率が大きすぎると本発明の目的を達成すること
が困難となる場合がある。The anchoring property of the patch of the present invention is not particularly limited, but when the anchoring property (residual rate to the skin) is measured by the anchoring property measuring method described in the examples below, it is 10 % Or less, and particularly preferably 5% or less.
If the residual rate is too large, it may be difficult to achieve the object of the present invention.
【0056】[0056]
【発明の効果】本発明によれば、支持体と含水ゲル層と
の投錨性に優れ、更に皮膚の伸縮によく追随し、且つ伸
長回復後もしわが入らず、良好な透明性を得ることも可
能な貼付剤が得られる。EFFECTS OF THE INVENTION According to the present invention, the anchoring property of the support and the hydrous gel layer is excellent, and further, it follows the expansion and contraction of the skin well, and does not have wrinkles even after the elongation recovery, and it is possible to obtain good transparency. A possible patch is obtained.
【0057】[0057]
【実施例】以下、実施例及び比較例を示し、本発明をよ
り具体的に説明するが、本発明は、下記実施例に限定さ
れるものではない。なお、以下の例において、%は質量
%である。EXAMPLES The present invention will be described in more detail below by showing Examples and Comparative Examples, but the present invention is not limited to the following Examples. In addition, in the following examples,% means mass%.
【0058】[実施例1]75デニールのポリエステル
の単糸を両面メリヤス編みした編布(坪量30g/
m2、上記50%伸長回復率100%、上記30%モジ
ュラス120g/cm)にポリウレタンフィルム(厚さ
30μm、上記透明度92、50%伸長回復率100
%、透湿度2250g/m2・24hr、上記30%モ
ジュラス100g/cm)をポリエステル系接着剤によ
り接着一体化して支持体(上記50%伸長回復率100
%、上記30%モジュラス150g/cm)とし、この
支持体の編布側に表1の実施例1に示した含水性膏体を
展延し、貼付剤を得た。Example 1 A knitted fabric in which a single yarn of 75 denier polyester was knitted on both sides (basis weight: 30 g /
m 2 , the above 50% elongation recovery rate 100%, the above 30% modulus 120 g / cm) and a polyurethane film (thickness 30 μm, the above transparency 92, 50% elongation recovery rate 100).
%, Water vapor transmission rate 2250 g / m 2 · 24 hr, the above 30% modulus 100 g / cm are bonded and integrated with a polyester adhesive to obtain a support (the above 50% elongation recovery rate 100).
%, The above 30% modulus was 150 g / cm), and the hydrous plaster shown in Example 1 of Table 1 was spread on the knitted fabric side of this support to obtain a patch.
【0059】[実施例2]50デニールのポリエステル
の単糸をフライメリヤス編みした編布(坪量20g/m
2、上記50%伸長回復率96%、上記30%モジュラ
ス100g/cm)にポリウレタンフィルム(厚さ25
μm、上記透明度85、50%伸長回復率100%、透
湿度1500g/m2・24hr、上記30%モジュラ
ス85g/cm)をポリウレタン系接着剤により接着一
体化して支持体(上記50%伸長回復率96%、上記3
0%モジュラス120g/cm)とし、この支持体の編
布側に表1の実施例2に示した含水性膏体を展延し、貼
付剤を得た。Example 2 A knitted fabric in which a single yarn of 50 denier polyester was knitted by fly knitting (basis weight: 20 g / m).
2 , the above 50% elongation recovery rate 96%, the above 30% modulus 100 g / cm) and a polyurethane film (thickness 25
μm, transparency 85, 50% elongation recovery rate 100%, water vapor transmission rate 1500 g / m 2 · 24 hr, 30% modulus 85 g / cm) bonded and integrated with a polyurethane adhesive to obtain a support (50% elongation recovery rate). 96%, above 3
With a 0% modulus of 120 g / cm), the hydrous plaster shown in Example 2 of Table 1 was spread on the knitted fabric side of this support to obtain a patch.
【0060】[実施例3]30デニールのポリプロピレ
ンの単糸を片面メリヤス編みした編布(坪量80g/m
2、上記50%伸長回復率97%、上記30%モジュラ
ス190g/cm)に押出機から溶融したポリウレタン
薄膜(厚さ20μm、上記透明度97、50%伸長回復
率100%、透湿度1000g/m2・24hr、上記
30%モジュラス70g/cm)を流し込み、熱融着し
一体化して支持体(上記50%伸長回復率97%、上記
30%モジュラス200g/cm)とし、この支持体の
編布側に表1の実施例3に示した含水性膏体を展延し、
貼付剤を得た。[Example 3] A knitted fabric in which a single yarn of 30 denier polypropylene was knitted on one side (basis weight: 80 g / m 2)
2. Polyurethane thin film (thickness 20 μm, transparency 97, 50% elongation recovery rate 100%, moisture permeability 1000 g / m 2 ) melted from an extruder to the above 50% elongation recovery rate 97% and the above 30% modulus 190 g / cm 2・ 24 hr, the above 30% modulus 70 g / cm) was poured and heat-sealed to be integrated into a support (the above 50% elongation recovery rate 97%, the above 30% modulus 200 g / cm), and the knitted fabric side of this support The water-containing plaster shown in Example 3 of Table 1 was spread on
A patch was obtained.
【0061】[実施例4]20デニールのポリウレタン
の単糸をトリコット編みした編布(坪量120g/
m2、上記50%伸長回復率100%、上記30%モジ
ュラス250g/cm)にポリウレタン溶液を塗布、乾
燥して、乾燥後の膜厚さが35μmの樹脂層(上記透明
度92、50%伸長回復率100%、透湿度250g/
m2・24hr、上記30%モジュラス150g/c
m)を積層して支持体(上記50%伸長回復率100
%、上記30%モジュラス270g/cm)とし、この
支持体の編布側に表1の実施例4に示した含水性膏体を
展延し、貼付剤を得た。[Example 4] A knitted fabric obtained by tricot knitting a single yarn of 20 denier polyurethane (basis weight: 120 g /
m 2 , the above 50% elongation recovery rate 100%, the above 30% modulus 250 g / cm) is applied with a polyurethane solution and dried to obtain a resin layer having a thickness of 35 μm after drying (transparency 92, 50% elongation recovery) 100%, moisture permeability 250g /
m 2 · 24 hr, above 30% modulus 150 g / c
m) are laminated to form a support (the above 50% elongation recovery rate is 100).
%, The above-mentioned 30% modulus was 270 g / cm), and the hydrous plaster shown in Example 4 of Table 1 was spread on the knitted fabric side of this support to obtain a patch.
【0062】[実施例5]50デニールのナイロンの単
糸を横編みした編布(坪量30g/m2、上記50%伸
長回復率98%、上記30%モジュラス110g/c
m)にポリエステル系フィルム(厚さ30μm、上記透
明度92、50%伸長回復率87%、透湿度500g/
m2・24hr、上記30%モジュラス180g/c
m)を高周波(ウェルダー法)により一体化して支持体
とし、この支持体(上記50%伸長回復率85%、上記
30%モジュラス220g/cm)の編布側に表1の実
施例5に示した含水性膏体を展延し、貼付剤を得た。[Example 5] A knitted fabric in which a single yarn of 50 denier nylon was flat-knitted (basis weight: 30 g / m 2 , 50% elongation recovery rate: 98%, 30% modulus: 110 g / c).
m) polyester film (thickness 30 μm, transparency 92, 50% elongation recovery 87%, moisture permeability 500 g /
m 2 · 24 hr, the above 30% modulus 180 g / c
m) was integrated by a high frequency (welder method) to form a support, and the support (50% elongation recovery rate 85%, 30% modulus 220 g / cm) of the support was shown in Example 5 of Table 1. The hydrous plaster was spread to obtain a patch.
【0063】[実施例6]75デニールのポリエステル
単糸と75デニールのポリプロピレン単糸の混糸を両面
メリヤス編みした編布(坪量10g/m2、上記50%
伸長回復率97%、上記30%モジュラス90g/c
m)に押出機から溶融したポリエステル系薄膜(厚さ3
0μm、上記透明度95、50%伸長回復率83%、透
湿度105g/m2・24hr、上記30%モジュラス
180g/cm)を流し込み、熱融着し一体化して支持
体とし、この支持体(上記50%伸長回復率80%、上
記30%モジュラス200g/cm)の編布側に表1の
実施例6に示した含水性膏体を展延し、貼付剤を得た。[Example 6] A knitted fabric in which a mixed yarn of 75 denier polyester single yarn and 75 denier polypropylene single yarn was knitted on both sides (basis weight: 10 g / m 2 , 50% above).
Elongation recovery rate 97%, above 30% modulus 90 g / c
m) polyester melted from the extruder (thickness 3
0 μm, the transparency 95, 50% elongation recovery rate 83%, water vapor transmission rate 105 g / m 2 · 24 hr, the above 30% modulus 180 g / cm) were poured, and heat fusion was performed to form a support. The hydrous plaster shown in Example 6 of Table 1 was spread on the knitted fabric side having a 50% elongation recovery rate of 80% and the above 30% modulus of 200 g / cm) to obtain a patch.
【0064】[実施例7]30デニールのポリエステル
単糸を二段の両面メリヤス編みした編布(坪量25g/
m2、上記50%伸長回復率100%、上記30%モジ
ュラス210g/cm)にポリウレタン系フィルム(厚
さ35μm、上記透明度82、50%伸長回復率100
%、透湿度1000g/m2・24hr、上記30%モ
ジュラス200g/cm)をポリウレタン系接着剤によ
り接着一体化して支持体(上記50%伸長回復率100
%、上記30%モジュラス220g/cm)とし、この
支持体の編布側に表1の実施例7に示した含水性膏体を
展延し、貼付剤を得た。[Example 7] A knitted fabric in which polyester single yarn of 30 denier was knitted in two steps on both sides (basis weight: 25 g /
m 2 , the above 50% elongation recovery rate 100%, the above 30% modulus 210 g / cm), and a polyurethane film (thickness 35 μm, the above transparency 82, 50% elongation recovery rate 100).
%, Water vapor transmission rate 1000 g / m 2 · 24 hr, the above 30% modulus 200 g / cm) are integrally bonded by a polyurethane adhesive to form a support (the above 50% elongation recovery rate 100).
%, The above-mentioned 30% modulus was 220 g / cm), and the hydrous plaster shown in Example 7 of Table 1 was spread on the knitted fabric side of this support to obtain a patch.
【0065】[実施例8]90デニールのポリプロピレ
ン製のマルチフィラメント糸を素材とし、これに捲縮加
工を施したものを用い、平編みに編成した編布(坪量8
0g/m2、上記50%伸長回復率100%、上記30
%モジュラス250g/cm)にポリウレタンフィルム
(厚さ25μm、上記透明度88、50%伸長回復率1
00%、透湿度400g/m2・24hr、上記30%
モジュラス85g/cm)をポリウレタン系接着剤によ
り接着一体化して支持体(上記50%伸長回復率100
%、上記30%モジュラス290g/cm)とし、この
支持体の編布側に表1の実施例8に示した含水性膏体を
展延し、貼付剤を得た。[Example 8] A knitted fabric knitted into a flat knit (a basis weight of 8) using a multifilament yarn made of polypropylene of 90 denier as a raw material and crimped
0 g / m 2 , above 50% elongation recovery rate 100%, above 30
% Modulus 250 g / cm) polyurethane film (thickness 25 μm, transparency 88, 50% elongation recovery 1
00%, moisture vapor transmission rate 400g / m 2 · 24hr, above 30%
A modulus (85 g / cm) is bonded and integrated with a polyurethane adhesive to form a support (the above 50% elongation recovery rate 100).
%, The above-mentioned 30% modulus was 290 g / cm), and the hydrous plaster shown in Example 8 of Table 1 was spread on the knitted fabric side of this support to obtain a patch.
【0066】[比較例1]1.5デニールのポリエステ
ルのウェブをニードルパンチして得た不織布(坪量10
0g/m2、上記50%伸長回復率72%、上記30%
モジュラス250g/cm)にポリウレタンフィルム
(厚さ30μm、上記透明度92、50%伸長回復率1
00%、透湿度2250g/m2・24hr、上記30
%モジュラス100g/cm)をポリエステル系接着剤
により接着一体化して支持体(上記50%伸長回復率7
0%、上記30%モジュラス270g/cm)とし、こ
の支持体の編布側に表1の比較例1に示した含水性膏体
を展延し、貼付剤を得た。[Comparative Example 1] A nonwoven fabric obtained by needle punching a polyester web of 1.5 denier (basis weight: 10).
0 g / m 2 , above 50% elongation recovery rate 72%, above 30%
Polyurethane film (thickness: 30 μm, transparency: 92, 50% elongation recovery rate: 1)
00%, moisture permeability 2250 g / m 2 · 24 hr, above 30
% Modulus 100 g / cm) is adhered and integrated with a polyester adhesive to obtain a support (50% elongation recovery rate 7 above).
0%, the above 30% modulus 270 g / cm), and the hydrous plaster shown in Comparative Example 1 of Table 1 was spread on the knitted fabric side of this support to obtain a patch.
【0067】[比較例2]20デニールのナイロン製の
単糸を用いた織布(坪量80g/m2、上記50%伸長
回復率61%、上記30%モジュラス850g/cm)
にポリウレタンフィルム(厚さ30μm、上記透明度9
2、50%伸長回復率100%、透湿度2250g/m
2・24hr、上記30%モジュラス100g/cm)
をポリエステル系接着剤により接着一体化して支持体
(上記50%伸長回復率59%、上記30%モジュラス
880g/cm)とし、この支持体の編布側に表1の比
較例2に示した含水性膏体を展延し、貼付剤を得た。[Comparative Example 2] A woven fabric using a 20-denier nylon single yarn (basis weight 80 g / m 2 , 50% elongation recovery rate 61%, 30% modulus 850 g / cm).
Polyurethane film (thickness 30 μm, transparency 9 above)
2,50% elongation recovery rate 100%, moisture vapor transmission rate 2250g / m
2 · 24hr, the 30% modulus of 100g / cm)
To a support (50% elongation recovery 59%, 30% modulus 880 g / cm) with a polyester adhesive, and the water content shown in Comparative Example 2 of Table 1 on the knitted fabric side of the support. The plaster was spread to obtain a patch.
【0068】上記実施例1〜8、比較例1、2の貼付剤
について、含水ゲルとの投錨性を下記評価方法によって
求め、上記50%伸長回復率を求めると共に、伸長回復
後の外観(支持体表面のしわ)を下記評価方法に従って
評価した。結果を表1に併記する。With respect to the patches of Examples 1 to 8 and Comparative Examples 1 and 2, the anchoring property with a hydrogel was determined by the following evaluation method to determine the 50% elongation recovery rate and the appearance after extension recovery (support). The wrinkles on the body surface) were evaluated according to the following evaluation methods. The results are also shown in Table 1.
【0069】<投錨性の評価方法>各貼付剤を皮膚(性
別;男、年齢20〜30才)に1分間貼付し、剥離した
時の全膏体量(含水ゲル量)に対する皮膚に残存した膏
体量の割合(%)を求めて、支持体と含水ゲルとの投錨
性の指標とした。<Evaluation Method of Anchoring Property> Each patch was applied to the skin (sex; male, age 20 to 30 years) for 1 minute and left on the skin relative to the total amount of plaster (hydrated gel amount) when peeled off. The ratio (%) of the amount of plaster was calculated and used as an index of the anchoring property between the support and the hydrogel.
【0070】<伸長回復後の外観(支持体表面のしわ)
>上記50%伸長回復率を測定した後の支持体を目視観
察し、支持体表面のしわを下記評価基準に基づいて評価
した。<Appearance after extension recovery (wrinkles on support surface)
The support after the above 50% elongation recovery rate was measured was visually observed, and the wrinkles on the surface of the support were evaluated based on the following evaluation criteria.
【0071】<評価基準> 全くしわがない :6 ほとんどしわがない:5 あまりしわがない :4 ややしわがある :3 かなりしわがある :2 非常にしわがある :1<Evaluation criteria> No wrinkles at all: 6 Almost no wrinkles: 5 No wrinkles: 4 There are some wrinkles: 3 Wrinkled: 2 Very wrinkled: 1
【0072】[0072]
【表1】 [Table 1]
【0073】
*1:ポリアクリル酸(ジュリマー10SH)
*2:ポリアクリル酸ナトリウム(アロンビス S)
*3:カルボキシビニルポリマー(カーボポール94
0)
*4:カルボキシメチルセルロースナトリウム(CMC
12380)
*5:アルギン酸ナトリウム(ダックアルギン)
*6:アクリル酸でんぷんグラフト重合体架橋物(サン
フレッシュIM−1000)
*7:アクリル酸塩重合体架橋物(サンフレッシュST
−500)
*8:エチレンオキサイド架橋体(アクアコーク)
*9:N−ビニルアセトアミド架橋体(ノニオレックス
IM−010)* 1: Polyacrylic acid (Jurimer 10SH) * 2: Sodium polyacrylate (Aronbis S) * 3: Carboxyvinyl polymer (Carbopol 94
0) * 4: Sodium carboxymethyl cellulose (CMC
12380) * 5: Sodium alginate (duck algin) * 6: Acrylic acid starch graft polymer crosslinked product (Sunfresh IM-1000) * 7: Acrylate polymer crosslinked product (Sunfresh ST
-500) * 8: Ethylene oxide crosslinked product (Aquacoke) * 9: N-vinylacetamide crosslinked product (Noniolex IM-010)
───────────────────────────────────────────────────── フロントページの続き (72)発明者 飯田 教雄 東京都墨田区本所1丁目3番7号 ライオ ン株式会社内 Fターム(参考) 4C081 AA03 AA12 BB04 BB07 BC02 CA021 CA041 CA081 CA161 CA211 CA231 DA02 DA05 DA12 DB01 DC04 DC05 DC06 EA03 EA06 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Norio Iida 1-3-7 Honjo, Sumida-ku, Tokyo Rio Within the corporation F-term (reference) 4C081 AA03 AA12 BB04 BB07 BC02 CA021 CA041 CA081 CA161 CA211 CA231 DA02 DA05 DA12 DB01 DC04 DC05 DC06 EA03 EA06
Claims (3)
させてなることを特徴とする貼付剤。1. A patch comprising a knitted fabric interposed between a resin layer and a hydrogel layer.
若しくは15〜500デニールのマルチフィラメント糸
からなり、且つ坪量が5〜150g/m2である請求項
1記載の貼付剤。2. The patch according to claim 1, wherein the knitted fabric is composed of a single yarn of 5 to 300 denier or a multifilament yarn of 15 to 500 denier and has a basis weight of 5 to 150 g / m 2 .
記載の貼付剤。3. The resin layer according to claim 1, wherein the resin layer is transparent.
The patch described above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002252700A JP2003169823A (en) | 2001-09-27 | 2002-08-30 | Patch |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001296518 | 2001-09-27 | ||
JP2001-296518 | 2001-09-27 | ||
JP2002252700A JP2003169823A (en) | 2001-09-27 | 2002-08-30 | Patch |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003169823A true JP2003169823A (en) | 2003-06-17 |
Family
ID=26623075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002252700A Pending JP2003169823A (en) | 2001-09-27 | 2002-08-30 | Patch |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003169823A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005304791A (en) * | 2004-04-21 | 2005-11-04 | Nitto Denko Corp | Dressing material with backing material |
WO2008016077A1 (en) * | 2006-08-04 | 2008-02-07 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
JPWO2005105150A1 (en) * | 2004-04-28 | 2008-03-13 | 久光製薬株式会社 | Patch |
JP2009219639A (en) * | 2008-03-14 | 2009-10-01 | Seiren Co Ltd | Medical film base material |
JP2010252995A (en) * | 2009-04-24 | 2010-11-11 | Unimedical Inc | Wound covering material, and method for manufacturing the same |
CN1823745B (en) * | 2004-10-08 | 2010-12-08 | 狮王株式会社 | Patch |
RU2474418C2 (en) * | 2008-01-31 | 2013-02-10 | Хисамицу Фармасьютикал Ко., Инк. | Adhesive plaster |
-
2002
- 2002-08-30 JP JP2002252700A patent/JP2003169823A/en active Pending
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005304791A (en) * | 2004-04-21 | 2005-11-04 | Nitto Denko Corp | Dressing material with backing material |
JP4703559B2 (en) * | 2004-04-28 | 2011-06-15 | 久光製薬株式会社 | Patch |
JPWO2005105150A1 (en) * | 2004-04-28 | 2008-03-13 | 久光製薬株式会社 | Patch |
US7998590B2 (en) | 2004-04-28 | 2011-08-16 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive material |
KR101192228B1 (en) | 2004-10-08 | 2012-10-17 | 라이온 가부시키가이샤 | Patch |
CN1823745B (en) * | 2004-10-08 | 2010-12-08 | 狮王株式会社 | Patch |
US9233184B2 (en) | 2006-08-04 | 2016-01-12 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US8809615B2 (en) | 2006-08-04 | 2014-08-19 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
CN101442993B (en) * | 2006-08-04 | 2011-10-05 | 久光制药株式会社 | Patch preparation |
RU2441649C2 (en) * | 2006-08-04 | 2012-02-10 | Хисамицу Фармасьютикал Ко., Инк. | Adhesive product |
JP5230423B2 (en) * | 2006-08-04 | 2013-07-10 | 久光製薬株式会社 | Patch |
KR101420450B1 (en) * | 2006-08-04 | 2014-07-16 | 히사미쓰 세이야꾸 가부시키가이샤 | Adhesive preparation |
WO2008016077A1 (en) * | 2006-08-04 | 2008-02-07 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US8455376B2 (en) | 2006-08-04 | 2013-06-04 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive preparation |
US8382729B2 (en) | 2008-01-31 | 2013-02-26 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
RU2474418C2 (en) * | 2008-01-31 | 2013-02-10 | Хисамицу Фармасьютикал Ко., Инк. | Adhesive plaster |
JP2009219639A (en) * | 2008-03-14 | 2009-10-01 | Seiren Co Ltd | Medical film base material |
JP2010252995A (en) * | 2009-04-24 | 2010-11-11 | Unimedical Inc | Wound covering material, and method for manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101015491B1 (en) | Adhesive | |
KR20160046846A (en) | Cataplasm and method for producing same | |
JP5089933B2 (en) | Water-containing pressure-sensitive adhesive composition and patch using the same | |
JPWO2016104227A1 (en) | Poultice | |
JP5719554B2 (en) | Patch | |
JP2003169823A (en) | Patch | |
JP2002145763A (en) | Cataplasm | |
KR101178435B1 (en) | Water-Containing Adhesive Gel Sheet | |
JP4650613B2 (en) | Patch | |
JP2000072619A (en) | Sheetlike hydrous pack agent | |
JP2007210941A (en) | Composition for transparent or translucent water containing patch for external use, and transparent or translucent patch for external use utilizing the composition | |
JP2011012015A (en) | Plaster | |
JP5544935B2 (en) | Patch | |
JP2008247807A (en) | Gel pack material and method for producing gel pack material | |
JP2003095929A (en) | Plaster | |
JPH0247513B2 (en) | ||
JP2003119125A (en) | Chapped stratum corneum-improving sheet | |
KR20210065931A (en) | functional patch | |
JP2006104170A (en) | Patch and method for producing patch | |
JP2004033279A (en) | Patch | |
KR102636944B1 (en) | Patch and its manufacturing method | |
JP5577691B2 (en) | Patch | |
WO2014171538A1 (en) | Substrate for transdermal patch and transdermal patch using same | |
JP2001335428A (en) | Eye pack cosmetics | |
JPH03161436A (en) | Cataplasm |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Effective date: 20050628 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
A977 | Report on retrieval |
Effective date: 20061117 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061206 |
|
A02 | Decision of refusal |
Effective date: 20070404 Free format text: JAPANESE INTERMEDIATE CODE: A02 |